Abstract

The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy

Author(s): Miller David G

Issue: Mar/Apr 2012 - Volume 16, Number 2

View All Articles in Issue

Page(s): 94-96

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2012 Pg. 94-96 View Sample	The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Author(s): Miller David G
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Mar/Apr 2016 Pg. 95-96	Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Author(s): McCrory Gary
Mar/Apr 2018 Pg. 125-126	IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Author(s): Blankenship Cynthia
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 375	The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Author(s): Miller David G
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 35-36	U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Author(s): Miller David G
Sep/Oct 2011 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Jan/Feb 2018 Pg. 26-28	The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Author(s): Blankenship Cynthia
Mar/Apr 2017 Pg. 116-117	The International Academy of Compounding Pharmacists Introduces a New President Author(s): Rice Baylor
Jul/Aug 2007 Pg. 326-327	Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Author(s): Kupiec Tom, Kemp Jesse
Sep/Oct 2009 Pg. 400-403	Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Author(s): Gilbert John A
Mar/Apr 2014 Pg. 117-118	IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Author(s): Miller David G